Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1D | Q01668 | 6/20 | 0.66 |
| ▸ | CACNA1C | Q13936 | 5/20 | 0.66 |
| ▸ | CACNA1F | O60840 | 4/20 | 0.66 |
| ▸ | CACNA1S | Q13698 | 4/20 | 0.66 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.66 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.66 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.66 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.66 |
| ▸ | SCN1A | P35498 | 2/20 | 0.66 |
| ▸ | HTR2B | P41595 | 2/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.66 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.66 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.66 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.66 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1639970 | 0.96 | CACNA1C (0.64) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL6720778 | 0.89 | CACNA1C (0.69) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL6720781 | 0.85 | CACNA1B (0.68) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL10909420 | 0.85 | ADORA3 (0.77) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL6720786 | 0.85 | CACNA1B (0.68) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL1639994 | 0.85 | CACNA1C (0.81) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL10899664 | 0.85 | CACNA1C (0.66) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL6727785 | 0.84 | CACNA1D (0.72) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL11527403 | 0.83 | CACNA1C (0.60) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 | |
| SCHEMBL10901098 | 0.83 | CACNA1C (0.66) | CACNA1DCACNA1CCACNA1FCACNA1SADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150335628-A1 | OLIGOMER-CALCIUM CHANNEL BLOCKER CONJUGATES | NEKTAR THERAPEUTICS | 2015-11-26 | — | — | US | disclosed |
| US-8748648-B2 | Oligomer-calcium channel blocker conjugates | NEKTAR THERAPEUTICS (US) | 2014-06-10 | — | — | US | disclosed |
| US-20110098273-A1 | Oligomer-Calcium Channel Blocker Conjugates | NEKTAR THERAPEUTICS (US) | 2011-04-28 | — | — | US | disclosed |
| EP-2125027-A2 | DE NOVO SYNTHESIS OF CONJUGATES | Nektar Therapeutics (US) | 2009-12-02 | — | — | EP | disclosed |
| WO-2009032286-A2 | OLIGOMER-CALCIUM CHANNEL BLOCKER CONJUGATES | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2009-03-12 | — | — | WO | disclosed |
| WO-2008112286-A9 | DE NOVO SYNTHESIS OF CONJUGATES | NEKTAR THERAPEUTICS AL CORP (US) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008112286-A2 | DE NOVO SYNTHESIS OF CONJUGATES | NEKTAR THERAPEUTICS (US) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150335628-A1 | OLIGOMER-CALCIUM CHANNEL BLOCKER CONJUGATES | ORAI1, CACNB2, CACNA1B | CACNA1D 18/4885CACNA1C 8/4885CACNA1F 13/4885 |
| US-20110098273-A1 | Oligomer-Calcium Channel Blocker Conjugates | ORAI1, CACNB2, CACNA1B | CACNA1D 18/4885CACNA1C 8/4885CACNA1F 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.